Pharmaceutical - Markets & Marketing, Licensing

Filter

Popular Filters

1 to 25 of 57 results

Cipla enters joint venture in Morocco and eyes Serum Institute of India merger

Cipla enters joint venture in Morocco and eyes Serum Institute of India merger

09-02-2015

Indian pharma company Cipla has announced that its UK subsidiary has entered into a joint venture agreement…

CiplaLicensingMarkets & MarketingMergers & AcquisitionsMoroccoPharmaceutical

Gedeon Richter enters license and distribution deal with Bayer

Gedeon Richter enters license and distribution deal with Bayer

27-01-2015

Hungary’s largest drugmaker Gedeon Richter says that it has entered into a license and distribution…

BayerEuropeGedeon RichterLicensingLisvyMarkets & MarketingPharmaceuticalReproductiveSouth AmericaWomen's Health

Helsinn gains exclusive rights to commercialize Pharmacosmos' Monofer in the USA

Helsinn gains exclusive rights to commercialize Pharmacosmos' Monofer in the USA

08-01-2015

Swiss oncology specialist Helsinn and Danish anemia drugmaker Pharmacosmos have entered into an agreement…

HelsinnHematologyLicensingMarkets & MarketingMonoferPharmaceuticalPharmacosmos

Ariad partners with Angelini on Iclusing in Central/Eastern Europe

Ariad partners with Angelini on Iclusing in Central/Eastern Europe

31-12-2014

US specialty pharma firm Ariad Pharmaceuticals has granted Italian drugmaker Angelini exclusive rights…

AngeliniAriad PharmaceuticalsEastern EuropeIclusigLicensingMarkets & MarketingOncologyPharmaceutical

Big pharma increasingly collaborating with Indian companies

Big pharma increasingly collaborating with Indian companies

26-11-2014

Even as multinational pharma majors are looking for new ways to squeeze costs along the whole value chain,…

Gilead SciencesIndiaLicensingMarkets & MarketingMergers & AcquisitionsPharmaceuticalRussia

Trimel and Endo agree on Natesto manufacturing and marketing collaboration

Trimel and Endo agree on Natesto manufacturing and marketing collaboration

24-11-2014

Trimel Biopharma, a subsidiary of Canada's Trimel Pharmaceuticals Corp, has signed an agreement with…

CanadaEndoLicensingMarkets & MarketingMen's HealthPharmaceuticalTrimel PharmaceuticalsUSA

Boehringer Ingelheim and Lilly revise diabetes alliance in certain countries

29-10-2014

In a move that will strengthen their 2011 alliance by enhancing efficiencies and enabling greater focus…

Boehringer IngelheimDiabetesEli LillyJardianceJentaduetoLicensingMarkets & MarketingPharmaceuticalTrajenta

Hikma to distribute Eisai’s Fycompa in Middle East

13-10-2014

Hikma Pharmaceuticals has entered into a partnership with Japanese pharma major Eisai for the distribution…

EisaiFycompaHikma PharmaceuticalsJordanLicensingMarkets & MarketingNeurologicalPharmaceuticalRest of the WorldSaudi Arabia

Ablynx out-licenses ozoralizumab for Greater China to Eddingpharm

Ablynx out-licenses ozoralizumab for Greater China to Eddingpharm

01-09-2014

Belgian drug developer Ablynx has expanded its relationship with China’s Eddingpharm, by granting the…

AblynxAnti-Arthritics/RheumaticsChinaEddingpharmLicensingMarkets & MarketingozoralizumabPharmaceutical

Daiichi Sankyo links with Kaketsuken for Bimmugen sales

28-08-2014

Japanese drug major Daiichi Sankyo has signed a cooperative sales agreement with The Chemo-Sero-Therapeutic…

Anti-viralsBimmugenDaiichi SankyoJapanKaketsukenLicensingMarkets & MarketingPharmaceuticalVaccines

Otsuka and Takeda to co-promote TAK-438 in the GI therapy area in Japan

Otsuka and Takeda to co-promote TAK-438 in the GI therapy area in Japan

29-03-2014

Japanese drugmakers Otsuka Pharmaceutical and Takeda Pharmaceutical have entered into a co-promotion…

Asia-PacificGastro-intestinalsJapanLicensingMarkets & MarketingOtsukaPharmaceuticalTAK-438Takeda Pharmaceuticalsvonoprazan

SIFI and NovaMedica link up to market eye care products in Russia

SIFI and NovaMedica link up to market eye care products in Russia

26-03-2014

Italian developer of innovative eye care solutions SIFI SpA Russian pharmaceutical company NovaMedica…

Eastern EuropeLicensingMarkets & MarketingNovaMedicaOphthalmicsPharmaceuticalRussiaSIFI SpA

Kyowa Hakko and LEO Pharma partner on topical calcipotriol/betamethasone dipropionate in Japan

26-12-2013

Japanese drugmaker Kyowa Hakko Kirin and Denmark’s privately-held dermatology specialist LEO Pharma…

Asia-PacificBetamethasone DipropionatecalcipotriolDermatologicalsKyowa Hakko KirinLEO PharmaLicensingMarkets & MarketingPharmaceutical

Sanofi to commercialize Vivus ED drug in Africa, Middle East, Turkey and CIS/Russia

Sanofi to commercialize Vivus ED drug in Africa, Middle East, Turkey and CIS/Russia

12-12-2013

US drugmaker Vivus has entered into a license and commercialization agreement with French pharma major…

avanafilEastern EuropeLicensingMarkets & MarketingMen's HealthPharmaceuticalRest of the WorldSanofiVivus

NovaMedica to distribute Aptalis products in Russia

06-12-2013

Russian drugmaker NovaMedica, a joint enterprise between the Russian high-technology investment fund…

Aptalis PharmaEastern EuropeGastro-intestinalsLicensingMarkets & MarketingNovaMedicaPharmaceuticalRussia

AstraZeneca to co-promote Janssen prostate cancer drug in Japan

AstraZeneca to co-promote Janssen prostate cancer drug in Japan

11-10-2013

Anglo-Swedish drug major AstraZeneca has entered into an agreement with US health care giant Johnson…

abirateroneAsia-PacificAstraZenecaJanssenJohnson & JohnsonLicensingMarkets & MarketingOncologyPharmaceuticalZytiga

Nippon Shinyaku and Pfizer conclude exclusive sales promotion on Tramal

30-09-2013

Nippon Shinyaku and Pfizer have concluded an exclusive sales promotion consignment contract in Japan…

Asia-PacificLicensingMarkets & MarketingNeurologicalNippon ShinyakuPfizerPharmaceuticalTramadol Hydrochloride

Merck & Co to co-promote diabetes agent ipragliflozin in Japan

02-09-2013

Japanese drug major Astellas Pharma (TYO: 4503) has entered into a co-promotion agreement in Japan with…

Asia-PacificAstellas PharmaDiabetesipragliflozinKotobuki PharmaceuticalLicensingMarkets & MarketingMerck & CoPharmaceutical

Mayne Pharma signs up deals to market Subacap in Europe

12-08-2013

Australian drugmaker Mayne Pharma (ASX: MYX) says it has signed two marketing and distribution agreements…

DermatologicalsEuropeGlenmark PharmaceuticalsIsdinitraconazoleLicensingMarkets & MarketingMayne PharmaPharmaceuticalSubacap

US FTC will continue to challenge "anticompetitive" pharma pay-for-delay deals

24-07-2013

The Federal Trade Commission told a Senate Judiciary subcommittee yesterday (July 23) that it will continue…

GenericsLegalLicensingMarkets & MarketingNorth AmericaPharmaceutical

Vivus partners with Menarini for European and Australia/NZ marketing of ED drug

09-07-2013

US drugmaker Vivus (Nasdaq: VVUS) has entered into a license and commercialization agreement and a supply…

Asia-PacificavanafilEuropeLicensingMarkets & MarketingMen's HealthMenariniPharmaceuticalReproductiveSpedraVivus

Teva pays $40 million upfront to market Alexza's Adasuve in USA

09-05-2013

The US subsidiary of Israeli generics giant Teva Pharmaceuticals Industries (NYSE: TEVA) has entered…

AdasuveAlexza PharmaceuticalLicensingMarkets & MarketingNeurologicalNorth AmericaPharmaceuticalTeva Pharmaceutical Industries

OPKO Health acquires 10% stake in Russia's Pharmsynthez

19-04-2013

USA-based OPKO Health (NYSE: OPK) says it has acquired an approximate 10% stake in OAO Pharmsynthez (MICEX:…

EuropeLicensingMarkets & MarketingMergers & AcquisitionsOPKO HealthPharmaceuticalPharmsynthez

1 to 25 of 57 results

COMPANY SPOTLIGHT

Menarini

Back to top